Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
Type of Publication
Journal Article
Year of Publication
2020
Journal
The Lancet Diabetes and Endocrinology
Language
Eng
Volume
8
Number of Pages
582 - 593
Links to full text